Free Trial

Petros Pharmaceuticals (PTPI) News Today

→ Collect 10%+ Dividends from AI's Explosive Growth? (From The Oxford Club) (Ad)
Free PTPI Stock Alerts
$0.42
-0.05 (-10.74%)
(As of 06/14/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends
June 8, 2024 | americanbankingnews.com
Petros Pharmaceuticals (NASDAQ:PTPI) & COMPASS Pathways (NASDAQ:CMPS) Head to Head Survey
May 29, 2024 | finance.yahoo.com
Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
May 21, 2024 | finance.yahoo.com
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
May 16, 2024 | investorplace.com
PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
April 25, 2024 | finance.yahoo.com
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
April 23, 2024 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Health
April 18, 2024 | markets.businessinsider.com
Positive Outlook for Petros Pharmaceuticals: Buy Rating Affirmed Amidst FDA Advances and Promising Stendra Developments
April 2, 2024 | markets.businessinsider.com
Petros Pharma Stock Down, Despite Positive Results For Stendra Study
April 2, 2024 | investorplace.com
PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 20, 2024 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
March 6, 2024 | morningstar.com
Petros Pharmaceuticals Inc Ordinary Shares PTPI
February 14, 2024 | finance.yahoo.com
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
February 14, 2024 | marketbeat.com
Trading was temporarily halted for "PTPI" at 09:02 AM with a stated reason of "LULD pause."
January 30, 2024 | uk.investing.com
Petros Pharmaceuticals Inc (PTPI)
January 24, 2024 | finance.yahoo.com
Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch
January 17, 2024 | finance.yahoo.com
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
December 14, 2023 | markets.businessinsider.com
Buy Rating on Petros Pharmaceuticals Amid Positive User Experience and Strategic FDA Pathway Compliance
December 12, 2023 | benzinga.com
Petros Pharma Stock (NASDAQ:PTPI) Insider Trades
December 12, 2023 | finance.yahoo.com
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider
December 12, 2023 | finance.yahoo.com
Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status
December 9, 2023 | nasdaq.com
Maxim Group Initiates Coverage of Petros Pharmaceuticals (PTPI) with Buy Recommendation
December 9, 2023 | benzinga.com
Petros Pharma Stock (NASDAQ:PTPI), Analyst Ratings, Price Targets, Predictions
December 8, 2023 | realmoney.thestreet.com
Petros Pharmaceuticals initiated with bullish view at Maxim
December 7, 2023 | morningstar.com
Petros Pharmaceuticals Inc Ordinary Shares
December 5, 2023 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's OTC Switch Technology Provider
December 5, 2023 | finance.yahoo.com
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's (rosuvastatin) OTC Switch Technology Provider
October 30, 2023 | finance.yahoo.com
Petros Pharmaceuticals Petros Pharmaceuticals Developing Artificial Intelligence Technology for Phase 2 Equivalent Study for STENDRA(R)
October 19, 2023 | finance.yahoo.com
Following Encouraging FDA Feedback Petros Pharmaceuticals Initiates Self-Selection (Phase 2-Equivalent) Study for STENDRA
October 4, 2023 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Label
October 4, 2023 | finance.yahoo.com
Petros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Label
September 28, 2023 | finance.yahoo.com
Petros Pharmaceuticals to Present at the LD Micro Main Event XVI
September 11, 2023 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Provides Letter to Shareholders
September 11, 2023 | finance.yahoo.com
Petros Pharmaceuticals Provides Letter to Shareholders
September 6, 2023 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 6, 2023 | finance.yahoo.com
Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
July 14, 2023 | marketwatch.com
Petros Pharmaceuticals Down 9% After Capital Raise News
July 13, 2023 | benzinga.com
Petros Pharmaceuticals Announces $15M Private Placement
July 13, 2023 | finance.yahoo.com
Petros Pharmaceuticals Announces Capital Raise of $15 Million
July 12, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 11:07 AM with a stated reason of "LULD pause."
July 12, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 11:07 AM with a stated reason of "LULD pause."
April 21, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 09:04 AM with a stated reason of "LULD pause."
April 20, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 10:04 AM with a stated reason of "LULD pause."
April 20, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 09:04 AM with a stated reason of "LULD pause."
April 18, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 09:04 AM with a stated reason of "LULD pause."
April 17, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 10:04 AM with a stated reason of "LULD pause."
April 17, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 09:04 AM with a stated reason of "LULD pause."
April 14, 2023 | msn.com
US Equity Futures Mixed Ahead of Retail Sales, Industrial Production, Consumer Sentiment Reports
April 14, 2023 | investorplace.com
Why Is Petros Pharmaceuticals (PTPI) Stock Up 101% Today?
March 6, 2023 | marketbeat.com
Trading was temporarily halted for "PTPI" at 09:03 AM with a stated reason of "LULD pause."
November 30, 2022 | finanznachrichten.de
Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Reverse Stock Split
Get Petros Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter.

Collect 10%+ Dividends from AI's Explosive Growth? (Ad)

What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?

Click here now to claim your FREE copy of Marc's AI playbook.

PTPI Media Mentions By Week

PTPI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PTPI
News Sentiment
▼
0.30

0.89
▲
Average
Medical
News Sentiment

PTPI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PTPI Articles
This Week
▼
3

0
▲
PTPI Articles
Average Week

Get Petros Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:PTPI) was last updated on 6/14/2024 by MarketBeat.com Staff

From Our Partners
Hurry! Buy this stock before the Robinhood traders do!
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
The #1 Crypto That You Don’t Own… Yet
There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...
Crypto 101 Media | Sponsored
President Kamala
The sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...
Stansberry Research | Sponsored
Tiny, One-Half Inch Pellet the Key to INFINITE Energy?
It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...
Eagle Publishing | Sponsored
Collect 10%+ Dividends from AI's Explosive Growth?
What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...
The Oxford Club | Sponsored
Biden’s Tax Plan Could Destroy Your Retirement Savings!
Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...
GoldenCrest Metals | Sponsored
The Single Biggest Breakthrough of the Decade
Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...
Porter & Company | Sponsored
Estee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI company
A Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.
Financial Markets Daily | Sponsored